Applications of N-Acetyl-3,5-Dinitro-L-Tyrosine in Industrial Manufacturing

N-Acetyl-3,5-Dinitro-L-Tyrosine serves as a specialized intermediate and functional additive across several advanced chemical sectors. We support downstream industrial partners by supplying verified material for integration into strictly-regulated manufacturing processes, where quality, purity, and traceability remain essential for controlled end-use development.

1. Active Pharmaceutical Ingredient (API) Synthesis for Peptide Drug Development

N-Acetyl-3,5-Dinitro-L-Tyrosine functions as a nitro-tyrosine derivative in synthetic peptide chemistry. Pharmaceutical manufacturers introduce this compound at specific stages of solid-phase peptide synthesis (SPPS) and solution-phase cluster assembly, particularly for site-specific modification and targeted bioactivity studies. The precise acetylation and dual nitration pattern provide unique binding characteristics needed in research peptides and select API candidates under clinical development.

Industry compliance standards

• ICH Q7: Good Manufacturing Practice for Active Pharmaceutical Ingredients
• USP <823>: Radiopharmaceuticals for Positron Emission Tomography—Compounding
• European Pharmacopoeia Monograph 2034 for amino acid derivatives
• FDA 21 CFR Part 211: Current Good Manufacturing Practice in Manufacturing, Processing, Packing, or Holding of Drugs

Typical usage ratio

• 0.1–2.5 molar equivalents relative to target amino acid residues; adjusted per specific peptide length and modification site frequency

Downstream process integration

• Material incorporated during coupling cycles in automated synthesizers or manual batch reactors; often deployed at protected side-chain insertion points
• N-acetylation and nitro group stability monitored during deprotection and cleavage phases

Final product types

• Modified research peptides for preclinical pharmacology studies
• Analytical calibration standards for bioassay and mass spectrometry laboratories
• Experimental APIs used in early-stage cancer, neurodegeneration, or inflammatory drug screening
• Tumor-targeted peptide-drug conjugates (PDCs) under process validation

2. Diagnostic Reagent Development for Protein Nitration Analysis

Laboratories developing immunoassay kits for the detection of protein tyrosine nitration utilize this material as a calibrator and hapten standard. The dinitro functionalization supports specific antibody affinity, allowing researchers and diagnostic kit manufacturers to measure peroxynitrite-induced protein modifications in clinical or biological samples. This application requires traceable high-purity material for consistent and reproducible test results in medical diagnostics.

Industry compliance standards

• ISO 13485:2016 – Quality Management Systems for Medical Devices and In Vitro Diagnostics
• FDA 21 CFR 820: Quality System Regulation for Medical Devices
• CLSI EP17-A2: Protocols for Detection of Limits of Blank, Detection, and Quantitation
• IVDR (EU) 2017/746 for in vitro diagnostic medical devices

Typical usage ratio

• 0.05–0.5 µg/ml as standard concentration in ELISA or Western blot standard curves; determined by required detection range and limit of quantification

Downstream process integration

• Material dissolved and aliquoted for direct use in plate-coating buffers or assay calibrators during diagnostic kit assembly
• Batch QC verified by HPLC and mass spectrometry prior to kit packaging

Final product types

• ELISA kits for protein nitration biomarker analysis
• Western blot reference controls for post-translational modification detection
• In vitro diagnostic reagents for cardiovascular and neurodegenerative disease studies
• Antibody affinity evaluation kits

3. Research Chemical Supply for Oxidative Stress and Redox Biology Studies

Academic and industrial research groups apply this compound as a model substrate for evaluating oxidative protein modifications in cell-free systems and living tissues. The unique dinitro acetyl tyrosine structure facilitates tracing of nitration events, protein labeling, and mechanistic studies of redox signaling. The research sector demands batch-to-batch reproducibility and detailed characterization, including chiral purity and isotope labeling when required.

Industry compliance standards

• ISO 9001:2015 Quality Management for Speciality Chemicals
• OECD Good Laboratory Practice (GLP) for nonclinical safety studies
• Sigma-Aldrich Chemical Quality Documentation
• Material Safety Data Sheet (MSDS) and REACH compliance for laboratory chemicals

Typical usage ratio

• 10–100 µM final concentration in cell culture or oxidative modification protocols; titrated to model nitrosative stress levels

Downstream process integration

• Dosed into assay plates, cell lysates, or tissue homogenates immediately prior to kinetic studies
• Used with radiolabel or biotinylation techniques for tracking incorporation

Final product types

• Experimental kits for oxidative stress research
• Protein modification analysis panels
• Standardized substrates for academic laboratory protocols
• Labelled protein and peptide conjugates for advanced imaging

4. Fine Chemical Intermediate for Custom Functional Polymer Manufacturing

Specialty polymer producers use N-acetyl-dinitro-tyrosine as a building block for the synthesis of functionalized macromolecules, including biodegradable polyamides and specialized hydrogels. The combination of aromatic nitro groups and a protected amine enables selective polymer backbone modification, introducing tailored reactivity or detection properties particularly in biomedical and sensor device applications. Process requirements dictate strict control of reaction parameters and impurity profiles to ensure compatibility with downstream polymerization technologies.

Industry compliance standards

• ISO 9001:2015 Quality Management for Polymer Raw Materials
• ISO 15378: Good Manufacturing Practice for Primary Packaging Materials
• REACH Registration and Safety Assessment for intermediates
• ASTM F1980: Accelerated Aging of Sterile Barrier Systems for Medical Devices (if used in biomedical hydrogels)

Typical usage ratio

• 0.5–3% by weight of total monomer feed; ratio adjusted depending on target functionality, crosslink density, and required nitro group presence

Downstream process integration

• Pre-polymerization stage blending with base monomers in solution polymerization reactors
• Monitored via spectroscopic analysis to verify nitro group retention in finished polymer

Final product types

• Biofunctional polyamide and polyurea microcapsules
• Medical hydrogel sensors with covalently integrated aromatic nitro groups
• Polymer support beads for chromatographic and biocatalysis applications
• Customizable polymer membranes for laboratory and microfluidic use